|
1
|
Gordon R: Skin cancer: An overview of
epidemiology and risk factors. Semin Oncol Nurs. 29:160–169. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Linares MA, Zakaria A and Nizran P: Skin
cancer. Prim Care. 42:645–659. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Prieto-Granada C and Rodriguez-Waitkus P:
Cutaneous squamous cell carcinoma and related entities:
Epidemiology, clinical and histological features, and basic science
overview. Curr Probl Cancer. 39:206–215. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Burton KA, Ashack KA and Khachemoune A:
Cutaneous squamous cell carcinoma: A review of high-risk and
metastatic disease. Am J Clin Dermatol. 17:491–508. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Farazi TA, Hoell JI, Morozov P and Tuschl
T: MicroRNAs in human cancer. Adv Exp Med Biol. 774:1–20. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bai X, Zhou Y, Chen P, Yang M and Xu J:
MicroRNA-142-5p induces cancer stem cell-like properties of
cutaneous squamous cell carcinoma via inhibiting PTEN. J Cell
Biochem. 119:2179–2188. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lin N, Zhou Y, Lian X and Tu Y:
MicroRNA-31 functions as an oncogenic microRNA in cutaneous
squamous cell carcinoma cells by targeting RhoTBT1. Oncol Lett.
13:1078–1082. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhou M, Zhou L, Zheng L, Guo L, Wang Y,
Liu H, Ou C and Ding Z: miR-365 promotes cutaneous squamous cell
carcinoma (CSCC) through targeting nuclear factor I/B (NFIB). PLoS
One. 9:e1006202014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xu N, Zhang L, Meisgen F, Harada M,
Heilborn J, Homey B, Grandér D, Ståhle M, Sonkoly E and Pivarcsi A:
MicroRNA-125b down-regulates matrix metallopeptidase 13 and
inhibits cutaneous squamous cell carcinoma cell proliferation,
migration, and invasion. J Biol Chem. 287:29899–29908. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lin J, Ma JC, Yang J, Yin JY, Chen XX, Guo
H, Wen XM, Zhang TJ, Qian W, Qian J and Deng ZQ: Arresting of
miR-186 and releasing of H19 by DDX43 facilitate tumorigenesis and
CML progression. Oncogene. 37:2432–2443. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li J, Xia L, Zhou Z, Zuo Z, Xu C, Song H
and Cai J: MiR-186-5p upregulation inhibits proliferation,
metastasis and epithelial-to-mesenchymal transition of colorectal
cancer cell by targeting ZEB1. Arch Biochem Biophys. 640:53–60.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Niinuma T, Kai M, Kitajima H, Yamamoto E,
Harada T, Maruyama R, Nobuoka T, Nishida T, Kanda T, Hasegawa T, et
al: Downregulation of miR-186 is associated with metastatic
recurrence of gastrointestinal stromal tumors. Oncol Lett.
14:5703–5710. 2017.PubMed/NCBI
|
|
15
|
Huang T, Wang G, Yang L, Peng B, Wen Y,
Ding G and Wang Z: MiR-186 inhibits proliferation, migration, and
invasion of non-small cell lung cancer cells by downregulating Yin
Yang 1. Cancer Biomark. 21:221–228. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gou Y, Zhai F, Zhang L and Cui L: RUNX3
regulates hepatocellular carcinoma cell metastasis via targeting
miR-186/E-cadherin/EMT pathway. Oncotarget. 8:61475–61486. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang JJ, Wang DD, Du CX and Wang Y: Long
noncoding RNA ANRIL promotes cervical cancer development by acting
as a sponge of miR-186. Oncol Res. 26:345–352. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu L, Wang Y, Bai R, Yang K and Tian Z:
MiR-186 inhibited aerobic glycolysis in gastric cancer via HIF-1α
regulation. Oncogenesis. 5:e2242016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhou L, Gao R, Wang Y, Zhou M and Ding Z:
Loss of BAX by miR-365 promotes cutaneous squamous cell carcinoma
progression by suppressing apoptosis. Int J Mol Sci. 18:E11572017.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Stojadinovic O, Ramirez H, Pastar I,
Gordon KA, Stone R, Choudhary S, Badiavas E, Nouri K and
Tomic-Canic M: MiR-21 and miR-205 are induced in invasive cutaneous
squamous cell carcinomas. Arch Dermatol Res. 309:133–139. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang S, Cao KE, He Q, Yin Z and Zhou J:
miR-199a-5p induces cell invasion by suppressing E-cadherin
expression in cutaneous squamous cell carcinoma. Oncol Lett.
12:97–101. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Canueto J, Cardenoso-Alvarez E,
Garcia-Hernandez JL, Galindo-Villardón P, Vicente-Galindo P,
Vicente-Villardón JL, Alonso-López D, De Las Rivas J, Valero J,
Moyano-Sanz E, et al: MicroRNA (miR)-203 and miR-205 expression
patterns identify subgroups of prognosis in cutaneous squamous cell
carcinoma. Br J Dermatol. 177:168–178. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cai Z, Hao XY and Liu FX: MicroRNA-186
serves as a tumor suppressor in oral squamous cell carcinoma by
negatively regulating the protein tyrosine phosphatase SHP2
expression. Arch Oral Biol. 89:20–25. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ruan L, Chen J, Ruan L, Yang T and Wang P:
MicroRNA-186 suppresses lung cancer progression by targeting SIRT6.
Cancer Biomark. 21:415–423. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Islam F, Gopalan V and Lam AK: RETREG1
(FAM134B): A new player in human diseases: 15 years after the
discovery in cancer. J Cell Physiol. 233:4479–4489. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kasem K, Gopalan V, Salajegheh A, Lu CT,
Smith RA and Lam AK: The roles of JK-1 (FAM134B) expressions in
colorectal cancer. Exp Cell Res. 326:166–173. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Islam F, Gopalan V, Pillai S, Lu CT, Kasem
K and Lam AK: Promoter hypermethylation inactivate tumor suppressor
FAM134B and is associated with poor prognosis in colorectal cancer.
Genes Chromosomes Cancer. 57:240–251. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Islam F, Gopalan V, Wahab R, Smith RA,
Qiao B and Lam AK: Stage dependent expression and tumor suppressive
function of FAM134B (JK1) in colon cancer. Mol Carcinog.
56:238–249. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Islam F, Gopalan V, Vider J, Wahab R,
Ebrahimi F, Lu CT, Kasem K and Lam AKY: MicroRNA-186-5p
overexpression modulates colon cancer growth by repressing the
expression of the FAM134B tumour inhibitor. Exp Cell Res.
357:260–270. 2017. View Article : Google Scholar : PubMed/NCBI
|
